Ataru Inagaki
Shibuya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Real-World Antidepressant Treatment Persistence in Children and Adolescents with Major Depressive Disorder in Japan: A Retrospective Nationwide Claims-Based Study.
Journal: Neuropsychiatric disease and treatment
Published: February 21, 2026
An open-label, long-term extension, multicenter study to evaluate the safety and efficacy of venlafaxine extended release in Japanese outpatients with generalized anxiety disorder.
Journal: PCN reports : psychiatry and clinical neurosciences
Published: January 12, 2026
Response to "Clinical relevance of venlafaxine ER for generalized anxiety disorder".
Journal: Psychiatry and clinical neurosciences
Published: December 02, 2025
A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release in Japanese patients with generalized anxiety disorder.
Journal: Psychiatry and clinical neurosciences
Published: May 30, 2025
Increased Antidepressant Prescriptions for Children and Adolescents with Major Depressive Disorder in Japan Based on a Claims Database.
Journal: Neuropsychiatric disease and treatment
Published: April 28, 2025
Budget impact analysis of long-acting injections for the treatment of Schizophrenia in Japan.
Journal: Asian journal of psychiatry
Published: December 18, 2024
Authors' Reply: Japan's Telepsychiatry Dissemination: Current Status and Challenges.
Journal: Journal of medical Internet research
Published: December 09, 2024
Correction: Issues in the Adoption of Online Medical Care: Cross-Sectional Questionnaire Survey.
Journal: Journal of medical Internet research
Published: November 12, 2024
Issues in the Adoption of Online Medical Care: Cross-Sectional Questionnaire Survey.
Journal: Journal of medical Internet research
Published: July 11, 2024
Associations between readmission and patient-reported measures in acute psychiatric inpatients: a multicenter prospective longitudinal study.
Journal: Social psychiatry and psychiatric epidemiology
Published: February 20, 2024
Budget impact analysis of long acting injection for schizophrenia in Japan.
Journal: Journal of medical economics
Published: April 10, 2020
Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan.
Journal: Advances in therapy
Published: February 27, 2020
Last Updated: 09/26/2026